TNF and metabolic dysfunction-associated steatohepatitis: As shown in Fig. 8A, the Sod1-specific inhibitor LCS-1 was intraperitoneally injected one day after each infusion of Exo/ASO-TNF or Exo/2DG in CDAA diet-induced NASH model.